{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T10:13:58Z","timestamp":1779358438506,"version":"3.51.4"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Virol"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s00705-025-06325-2","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T06:39:30Z","timestamp":1748327970000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploiting the chikungunya virus capsid protein: a focused target for antiviral therapeutic development"],"prefix":"10.1007","volume":"170","author":[{"given":"Kavitha","family":"Karunakaran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul Ajees Abdul","family":"Salam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7034-5221","authenticated-orcid":false,"given":"Piya Paul","family":"Mudgal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,27]]},"reference":[{"issue":"4","key":"6325_CR1","doi-asserted-by":"publisher","first-page":"e107","DOI":"10.1016\/S1473-3099(16)30385-1","volume":"17","author":"FJ Burt","year":"2017","unstructured":"Burt FJ, Chen W, Miner JJ, Lenschow DJ, Merits A, Schnettler E, Kohl A, Rudd PA, Taylor A, Herrero LJ, Zaid A, Ng LFP, Mahalingam S (2017) Chikungunya virus: An update on the biology and pathogenesis of this emerging pathogen. Lancet Infect Dis 17(4):e107\u2013e117. https:\/\/doi.org\/10.1016\/S1473-3099(16)30385-1","journal-title":"Lancet Infect Dis"},{"key":"6325_CR2","unstructured":"Togaviridae | ICTV. (n.d.) from https:\/\/ictv.global\/report\/chapter\/togaviridae"},{"key":"6325_CR3","unstructured":"Schmaljohn AL, McClain D (1996) Alphaviruses (Togaviridae) and Flaviviruses (Flaviviridae). In S. Baron (Ed.), Medical Microbiology (4th ed.). University of Texas Medical Branch at Galveston. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK7633\/"},{"issue":"2","key":"6325_CR4","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1099\/0022-1317-81-2-471","volume":"81","author":"AM Powers","year":"2000","unstructured":"Powers AM, Brault AC, Tesh RB, Weaver SC (2000) Re-emergence of chikungunya and o\u2019nyong-nyong viruses: Evidence for distinct geographical lineages and distant evolutionary relationships. J Gen Virol 81(2):471\u2013479. https:\/\/doi.org\/10.1099\/0022-1317-81-2-471","journal-title":"J Gen Virol"},{"issue":"13","key":"6325_CR5","doi-asserted-by":"publisher","first-page":"6497","DOI":"10.1128\/JVI.01603-09","volume":"84","author":"SM Volk","year":"2010","unstructured":"Volk SM, Chen R, Tsetsarkin KA, Adams AP, Garcia TI, Sall AA, Nasar F, Schuh AJ, Holmes EC, Higgs S, Maharaj PD, Brault AC, Weaver SC (2010) Genome-Scale Phylogenetic Analyses of Chikungunya Virus Reveal Independent Emergences of Recent Epidemics and Various Evolutionary Rates. J Virol 84(13):6497\u20136504. https:\/\/doi.org\/10.1128\/JVI.01603-09","journal-title":"J Virol"},{"key":"6325_CR6","doi-asserted-by":"publisher","unstructured":"Schuffenecker I, Iteman I, Michault A, Murri S, Frangeul L, Vaney M-C, Lavenir R, Pardigon N, Reynes J-M, Pettinelli F, Biscornet L, Diancourt L, Michel S, Duquerroy S, Guigon G, Frenkiel M-P, Br\u00e9hin A-C, Cubito N, Despr\u00e8s P, Brisse S (2006) Genome Microevolution of Chikungunya Viruses Causing the Indian Ocean Outbreak. PLoS Med 3(7). https:\/\/doi.org\/10.1371\/journal.pmed.0030263","DOI":"10.1371\/journal.pmed.0030263"},{"key":"6325_CR7","unstructured":"Chikungunya fact sheet. (n.d.)from https:\/\/www.who.int\/newsroom\/factsheets\/detail\/ chikungunya"},{"issue":"4","key":"6325_CR8","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1080\/14787210.2019.1595591","volume":"17","author":"SM Bhat","year":"2019","unstructured":"Bhat SM, Mudgal PP, N, S., Arunkumar G (2019) Spectrum of candidate molecules against Chikungunya virus\u2014An insight into the antiviral screening platforms. Expert Rev Anti-Infective Therapy 17(4):243\u2013264. https:\/\/doi.org\/10.1080\/14787210.2019.1595591","journal-title":"Expert Rev Anti-Infective Therapy"},{"issue":"7","key":"6325_CR9","doi-asserted-by":"publisher","first-page":"taae123","DOI":"10.1093\/jtm\/taae123","volume":"31","author":"LH Chen","year":"2024","unstructured":"Chen LH, Fritzer A, Hochreiter R, Dubischar K, Meyer S (2024) From bench to clinic: The development of VLA1553\/IXCHIQ, a live-attenuated chikungunya vaccine. J Travel Med 31(7):taae123. https:\/\/doi.org\/10.1093\/jtm\/taae123","journal-title":"J Travel Med"},{"key":"6325_CR10","doi-asserted-by":"publisher","unstructured":"Ching K-C, Kam Y-W, Merits A, Ng LFP, Chai CLL (2015), November 19 Trisubstituted Thieno[3,2-b]pyrrole 5-Carboxamides as Potent Inhibitors of Alphaviruses (world) [Research-article]. ACS Publications; American Chemical Society. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b01047","DOI":"10.1021\/acs.jmedchem.5b01047"},{"key":"6325_CR11","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.virol.2016.08.029","volume":"498","author":"R Sharma","year":"2016","unstructured":"Sharma R, Fatma B, Saha A, Bajpai S, Sistla S, Dash PK, Parida M, Kumar P, Tomar S (2016) Inhibition of chikungunya virus by picolinate that targets viral capsid protein. Virology 498:265\u2013276. https:\/\/doi.org\/10.1016\/j.virol.2016.08.029","journal-title":"Virology"},{"key":"6325_CR12","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.12688\/f1000research.12301.2","volume":"6","author":"J Jain","year":"2017","unstructured":"Jain J, Kumari A, Somvanshi P, Grover A, Pai S, Sunil S (2017) In silico analysis of natural compounds targeting structural and nonstructural proteins of chikungunya virus. F1000Research 6:1601. https:\/\/doi.org\/10.12688\/f1000research.12301.2","journal-title":"F1000Research"},{"key":"6325_CR13","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.virol.2017.12.020","volume":"515","author":"R Sharma","year":"2018","unstructured":"Sharma R, Kesari P, Kumar P, Tomar S (2018) Structure-function insights into chikungunya virus capsid protein: Small molecules targeting capsid hydrophobic pocket. Virology 515:223\u2013234. https:\/\/doi.org\/10.1016\/j.virol.2017.12.020","journal-title":"Virology"},{"issue":"3","key":"6325_CR14","doi-asserted-by":"publisher","first-page":"e01382","DOI":"10.1128\/mBio.01382-20","volume":"11","author":"JJ Wan","year":"2020","unstructured":"Wan JJ, Brown RS, Kielian M (2020) Berberine Chloride is an Alphavirus Inhibitor That Targets Nucleocapsid Assembly. mBio 11(3):e01382\u2013e01320. https:\/\/doi.org\/10.1128\/mBio.01382-20","journal-title":"mBio"},{"key":"6325_CR15","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.virol.2021.05.013","volume":"561","author":"R Kumar","year":"2021","unstructured":"Kumar R, Nehul S, Singh A, Tomar S (2021) Identification and evaluation of antiviral potential of thymoquinone, a natural compound targeting Chikungunya virus capsid protein. Virology 561:36\u201346. https:\/\/doi.org\/10.1016\/j.virol.2021.05.013","journal-title":"Virology"},{"key":"6325_CR16","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.antiviral.2017.08.015","volume":"146","author":"M Aggarwal","year":"2017","unstructured":"Aggarwal M, Kaur R, Saha A, Mudgal R, Yadav R, Dash PK, Parida M, Kumar P, Tomar S (2017) Evaluation of antiviral activity of piperazine against Chikungunya virus targeting hydrophobic pocket of alphavirus capsid protein. Antiviral Res 146:102\u2013111. https:\/\/doi.org\/10.1016\/j.antiviral.2017.08.015","journal-title":"Antiviral Res"},{"key":"6325_CR17","doi-asserted-by":"publisher","first-page":"104808","DOI":"10.1016\/j.antiviral.2020.104808","volume":"179","author":"B Fatma","year":"2020","unstructured":"Fatma B, Kumar R, Singh VA, Nehul S, Sharma R, Kesari P, Kuhn RJ, Tomar S (2020) Alphavirus capsid protease inhibitors as potential antiviral agents for Chikungunya infection. Antiviral Res 179:104808. https:\/\/doi.org\/10.1016\/j.antiviral.2020.104808","journal-title":"Antiviral Res"},{"key":"6325_CR18","doi-asserted-by":"publisher","first-page":"1132538","DOI":"10.3389\/fcimb.2023.1132538","volume":"13","author":"B Kasabe","year":"2023","unstructured":"Kasabe B, Ahire G, Patil P, Punekar M, Davuluri KS, Kakade M, Alagarasu K, Parashar D, Cherian S (2023) Drug repurposing approach against chikungunya virus: An in vitro and in silico study. Front Cell Infect Microbiol 13:1132538. https:\/\/doi.org\/10.3389\/fcimb.2023.1132538","journal-title":"Front Cell Infect Microbiol"},{"key":"6325_CR19","doi-asserted-by":"publisher","unstructured":"Rabelo VW-H, da Silva VD, Sanchez Nu\u00f1ez ML, Dos Santos Corr\u00eaa Amorim L, Buarque CD, Kuhn RJ, Abreu PA (2023) & Nunes de Palmer Paix\u00e3o, I. C. Antiviral evaluation of 1,4-disubstituted-1,2,3-triazole derivatives against Chikungunya virus. Future Virology. 18(13):865\u2013880. https:\/\/doi.org\/10.2217\/fvl-2023-0142","DOI":"10.2217\/fvl-2023-0142"},{"key":"6325_CR20","doi-asserted-by":"publisher","unstructured":"Choi H-K, Tong L, Minor W, Dumas P, Boege U, Rossmann MG, Wengler G (1991) Structure of Sindbis virus core protein reveals a chymotrypsin-like serine proteinase and the organization of the virion. Nature 354(6348) Article 6348. https:\/\/doi.org\/10.1038\/354037a0","DOI":"10.1038\/354037a0"},{"issue":"3","key":"6325_CR21","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1128\/mr.58.3.491-562.1994","volume":"58","author":"JH Strauss","year":"1994","unstructured":"Strauss JH, Strauss EG (1994) The alphaviruses: Gene expression, replication, and evolution. Microbiol Rev 58(3):491\u2013562","journal-title":"Microbiol Rev"},{"key":"6325_CR22","doi-asserted-by":"publisher","first-page":"129949","DOI":"10.1016\/j.ijbiomac.2024.129949","volume":"262","author":"M Wang","year":"2024","unstructured":"Wang M, Wang L, Leng P, Guo J, Zhou H (2024) Drugs targeting structural and nonstructural proteins of the chikungunya virus: A review. Int J Biol Macromol 262:129949. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.129949","journal-title":"Int J Biol Macromol"},{"key":"6325_CR23","doi-asserted-by":"publisher","first-page":"3663","DOI":"10.2147\/DDDT.S366112","volume":"16","author":"C Schmidt","year":"2022","unstructured":"Schmidt C, Schnierle BS (2022) Chikungunya Vaccine Candidates: Current Landscape and Future Prospects. Drug Des Devel Ther 16:3663\u20133673. https:\/\/doi.org\/10.2147\/DDDT.S366112","journal-title":"Drug Des Devel Ther"},{"key":"6325_CR24","doi-asserted-by":"crossref","unstructured":"Velmurugan D, Manish K, Gayathri D (2019) Chikungunya Virus Infection: A Review of its Control and Treatment. Medicinal Chemistry of Neglected and Tropical Diseases. CRC","DOI":"10.1201\/9781351011655-6"},{"key":"6325_CR25","doi-asserted-by":"publisher","unstructured":"Weaver SC (2014) Arrival of Chikungunya Virus in the New World: Prospects for Spread and Impact on Public Health. PLoS Negl Trop Dis 8(6). https:\/\/doi.org\/10.1371\/journal.pntd.0002921","DOI":"10.1371\/journal.pntd.0002921"},{"issue":"1","key":"6325_CR26","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/0035-9203(55)90080-8","volume":"49","author":"MC Robinson","year":"1955","unstructured":"Robinson MC (1955) An epidemic of virus disease in Southern Province, Tanganyika territory, in 1952\u20131953. Trans R Soc Trop Med Hyg 49(1):28\u201332. https:\/\/doi.org\/10.1016\/0035-9203(55)90080-8","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"4","key":"6325_CR27","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.jaci.2015.01.039","volume":"135","author":"C Petitdemange","year":"2015","unstructured":"Petitdemange C, Wauquier N, Vieillard V (2015) Control of immunopathology during chikungunya virus infection. J Allergy Clin Immunol 135(4):846\u2013855. https:\/\/doi.org\/10.1016\/j.jaci.2015.01.039","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"6325_CR28","doi-asserted-by":"publisher","first-page":"5822","DOI":"10.1038\/s41598-018-23969-0","volume":"8","author":"A Singh","year":"2018","unstructured":"Singh A, Kumar A, Yadav R, Uversky VN, Giri R (2018) Deciphering the dark proteome of Chikungunya virus. Sci Rep 8(1):5822. https:\/\/doi.org\/10.1038\/s41598-018-23969-0","journal-title":"Sci Rep"},{"key":"6325_CR29","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1186\/1743-422X-10-269","volume":"10","author":"S Thomas","year":"2013","unstructured":"Thomas S, Rai J, John L, Schaefer S, P\u00fctzer BM, Herchenr\u00f6der O (2013) Chikungunya virus capsid protein contains nuclear import and export signals. Virol J 10:269. https:\/\/doi.org\/10.1186\/1743-422X-10-269","journal-title":"Virol J"},{"key":"6325_CR30","unstructured":"Bank RP D. (n.d.). RCSB PDB\u2013\u20095H23: Crystal structure of Chikungunya virus capsid protein https:\/\/www.rcsb.org\/structure\/5H23"},{"issue":"1\u20133","key":"6325_CR31","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.febslet.2004.08.017","volume":"574","author":"C-W Lin","year":"2004","unstructured":"Lin C-W, Tsai C-H, Tsai F-J, Chen P-J, Lai C-C, Wan L, Chiu H-H, Lin K-H (2004) Characterization of trans- and cis-cleavage activity of the SARS coronavirus 3CLpro protease: Basis for the in vitro screening of anti-SARS drugs. FEBS Lett 574(1\u20133):131\u2013137. https:\/\/doi.org\/10.1016\/j.febslet.2004.08.017","journal-title":"FEBS Lett"},{"issue":"9","key":"6325_CR32","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.1128\/AAC.01508-07","volume":"52","author":"NH Mueller","year":"2008","unstructured":"Mueller NH, Pattabiraman N, Ansarah-Sobrinho C, Viswanathan P, Pierson TC, Padmanabhan R (2008) Identification and biochemical characterization of small-molecule inhibitors of west nile virus serine protease by a high-throughput screen. Antimicrob Agents Chemother 52(9):3385\u20133393. https:\/\/doi.org\/10.1128\/AAC.01508-07","journal-title":"Antimicrob Agents Chemother"},{"issue":"18","key":"6325_CR33","doi-asserted-by":"publisher","first-page":"8848","DOI":"10.1128\/JVI.00619-06","volume":"80","author":"EM Hong","year":"2006","unstructured":"Hong EM, Perera R, Kuhn RJ (2006) Alphavirus Capsid Protein Helix I Controls a Checkpoint in Nucleocapsid Core Assembly. J Virol 80(18):8848\u20138855. https:\/\/doi.org\/10.1128\/JVI.00619-06","journal-title":"J Virol"},{"issue":"5","key":"6325_CR34","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1128\/jvi.61.5.1301-1309.1987","volume":"61","author":"P Melancon","year":"1987","unstructured":"Melancon P, Garoff H (1987) Processing of the Semliki Forest virus structural polyprotein: Role of the capsid protease. J Virol 61(5):1301\u20131309","journal-title":"J Virol"},{"key":"6325_CR35","doi-asserted-by":"publisher","first-page":"108822","DOI":"10.1016\/j.abb.2021.108822","volume":"702","author":"N Gaurav","year":"2021","unstructured":"Gaurav N, Tripathi PK, Kumar V, Chugh A, Sundd M, Patel AK (2021) Role of nuclear localization signals in the DNA delivery function of Chikungunya virus capsid protein. Arch Biochem Biophys 702:108822. https:\/\/doi.org\/10.1016\/j.abb.2021.108822","journal-title":"Arch Biochem Biophys"},{"issue":"4","key":"6325_CR36","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.virs.2023.05.007","volume":"38","author":"P Yin","year":"2023","unstructured":"Yin P, Jian X, Liu Y, Liu Y, Lv L, Cui H, Zhang L (2023) Elucidating cellular interactome of chikungunya virus identifies host dependency factors. Virol Sin 38(4):497\u2013507. https:\/\/doi.org\/10.1016\/j.virs.2023.05.007","journal-title":"Virol Sin"},{"issue":"2","key":"6325_CR37","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3390\/v10020089","volume":"10","author":"RS Brown","year":"2018","unstructured":"Brown RS, Wan JJ, Kielian M (2018) The Alphavirus Exit Pathway: What We Know and What We Wish We Knew. Viruses 10(2):89. https:\/\/doi.org\/10.3390\/v10020089","journal-title":"Viruses"},{"issue":"8","key":"6325_CR38","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1038\/s41564-022-01164-2","volume":"7","author":"D Chmielewski","year":"2022","unstructured":"Chmielewski D, Schmid MF, Simmons G, Jin J, Chiu W (2022) Chikungunya virus assembly and budding visualized in situ using cryogenic electron tomography. Nat Microbiol 7(8):1270\u20131279. https:\/\/doi.org\/10.1038\/s41564-022-01164-2","journal-title":"Nat Microbiol"},{"key":"6325_CR39","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.virol.2021.04.009","volume":"560","author":"LM Kiser","year":"2021","unstructured":"Kiser LM, Sokoloski KJ, Hardy RW (2021) Interactions between capsid and viral RNA regulate Chikungunya virus translation in a host-specific manner. Virology 560:34\u201342. https:\/\/doi.org\/10.1016\/j.virol.2021.04.009","journal-title":"Virology"},{"key":"6325_CR40","doi-asserted-by":"publisher","DOI":"10.3724\/abbs.2024073","author":"Y Yan","year":"2024","unstructured":"Yan Y, Zhang F, Zou M, Chen H, Xu J, Lu S, Liu H (2024) Identification of RACK1 as a novel regulator of non-structural protein 4 of chikungunya virus. Acta Biochim Biophys Sin. https:\/\/doi.org\/10.3724\/abbs.2024073","journal-title":"Acta Biochim Biophys Sin"},{"key":"6325_CR41","doi-asserted-by":"publisher","unstructured":"Identification of potential molecular associations between chikungunya virus non-structural protein 2 and human host proteins. (2017) https:\/\/doi.org\/10.4149\/av_2017_01_39","DOI":"10.4149\/av_2017_01_39"},{"key":"6325_CR42","doi-asserted-by":"publisher","unstructured":"Singh A, Kumar A, Uversky VN, Giri R (n.d.). Understanding the interactability of chikungunya virus proteins via molecular recognition feature analysis. RSC Adv, 8(48), 27293\u201327303. https:\/\/doi.org\/10.1039\/c8ra04760j","DOI":"10.1039\/c8ra04760j"},{"key":"6325_CR43","doi-asserted-by":"publisher","unstructured":"Yap ML, Klose T, Urakami A, Hasan SS, Akahata W, Rossmann MG (2017) Structural studies of Chikungunya virus maturation. Proceedings of the National Academy of Sciences. 114(52):13703\u201313707. https:\/\/doi.org\/10.1073\/pnas.1713166114","DOI":"10.1073\/pnas.1713166114"},{"issue":"1","key":"6325_CR44","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/infdis\/jiq006","volume":"204","author":"N Wauquier","year":"2011","unstructured":"Wauquier N, Becquart P, Nkoghe D, Padilla C, Ndjoyi-Mbiguino A, Leroy EM (2011) The Acute Phase of Chikungunya Virus Infection in Humans Is Associated With Strong Innate Immunity and T CD8 Cell Activation. J Infect Dis 204(1):115\u2013123. https:\/\/doi.org\/10.1093\/infdis\/jiq006","journal-title":"J Infect Dis"},{"issue":"6","key":"6325_CR45","doi-asserted-by":"publisher","first-page":"5146","DOI":"10.1128\/JVI.72.6.5146-5153.1998","volume":"72","author":"ML Linn","year":"1998","unstructured":"Linn ML, Mateo L, Gardner J, Suhrbier A (1998) Alphavirus-Specific Cytotoxic T Lymphocytes Recognize a Cross-Reactive Epitope from the Capsid Protein and Can Eliminate Virus from Persistently Infected Macrophages. J Virol 72(6):5146\u20135153","journal-title":"J Virol"},{"issue":"10","key":"6325_CR46","doi-asserted-by":"publisher","first-page":"e1008999","DOI":"10.1371\/journal.ppat.1008999","volume":"16","author":"LG Webb","year":"2020","unstructured":"Webb LG, Veloz J, Pintado-Silva J, Zhu T, Rangel MV, Mutetwa T, Zhang L, Bernal-Rubio D, Figueroa D, Carrau L, Fenutria R, Potla U, Reid SP, Yount JS, Stapleford KA, Aguirre S, Fernandez-Sesma A (2020) Chikungunya virus antagonizes cGAS-STING mediated type-I interferon responses by degrading cGAS. PLoS Pathog 16(10):e1008999. https:\/\/doi.org\/10.1371\/journal.ppat.1008999","journal-title":"PLoS Pathog"},{"key":"6325_CR47","doi-asserted-by":"publisher","unstructured":"Liu Y, Yuan Y, Zhang L (2022) Innate immune evasion by alphaviruses. Front Immunol 13. https:\/\/doi.org\/10.3389\/fimmu.2022.1005586","DOI":"10.3389\/fimmu.2022.1005586"},{"issue":"23","key":"6325_CR48","doi-asserted-by":"publisher","first-page":"13005","DOI":"10.1128\/JVI.01780-12","volume":"86","author":"Y-W Kam","year":"2012","unstructured":"Kam Y-W, Lee WWL, Simarmata D, Harjanto S, Teng T-S, Tolou H, Chow A, Lin RTP, Leo Y-S, R\u00e9nia L, Ng LFP (2012) Longitudinal Analysis of the Human Antibody Response to Chikungunya Virus Infection: Implications for Serodiagnosis and Vaccine Development. J Virol 86(23):13005\u201313015. https:\/\/doi.org\/10.1128\/JVI.01780-12","journal-title":"J Virol"},{"issue":"7","key":"6325_CR49","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.3390\/v13071307","volume":"13","author":"V Battisti","year":"2021","unstructured":"Battisti V, Urban E, Langer T (2021) Antivirals against the Chikungunya Virus. Viruses 13(7):1307. https:\/\/doi.org\/10.3390\/v13071307","journal-title":"Viruses"},{"issue":"2","key":"6325_CR50","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1128\/jvi.78.2.922-929.2004","volume":"78","author":"J Zhou","year":"2004","unstructured":"Zhou J, Yuan X, Dismuke D, Forshey BM, Lundquist C, Lee K-H, Aiken C, Chen CH (2004) Small-Molecule Inhibition of Human Immunodeficiency Virus Type 1 Replication by Specific Targeting of the Final Step of Virion Maturation. J Virol 78(2):922\u2013929. https:\/\/doi.org\/10.1128\/jvi.78.2.922-929.2004","journal-title":"J Virol"},{"issue":"1","key":"6325_CR51","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1248\/cpb.c23-00618","volume":"72","author":"T Kobayakawa","year":"2024","unstructured":"Kobayakawa T, Yokoyama M, Tsuji K, Boku S, Kurakami M, Fujino M, Ishii T, Miura Y, Nishimura S, Shinohara K, Yamamoto K, Bolah P, Kotani O, Murakami T, Sato H, Tamamura H (2024) Development of Small-Molecule Anti-HIV-1 Agents Targeting HIV-1 Capsid Proteins. Chemical Pharmaceutical Bulletin 72(1):41\u201347. https:\/\/doi.org\/10.1248\/cpb.c23-00618","journal-title":"Chemical Pharmaceutical Bulletin"},{"key":"6325_CR52","doi-asserted-by":"publisher","first-page":"105715","DOI":"10.1016\/j.antiviral.2023.105715","volume":"218","author":"J Xi","year":"2023","unstructured":"Xi J, Gu Z, Sun C, Chen Z, Zhang T, Chen R, Liu T, Liao H, Zou J, Yang D, Xu Q, Wang J, Wei G, Cheng Z, Lu F, Chen X (2023) A novel hepatitis B virus capsid assembly modulator QL-007 inhibits HBV replication and infection through altering capsid assembly. Antiviral Res 218:105715. https:\/\/doi.org\/10.1016\/j.antiviral.2023.105715","journal-title":"Antiviral Res"},{"issue":"24","key":"6325_CR53","doi-asserted-by":"publisher","first-page":"7420","DOI":"10.3390\/molecules26247420","volume":"26","author":"H Kim","year":"2021","unstructured":"Kim H, Ko C, Lee J-Y, Kim M (2021) Current Progress in the Development of Hepatitis B Virus Capsid Assembly Modulators: Chemical Structure, Mode-of-Action and Efficacy. Molecules 26(24):7420. https:\/\/doi.org\/10.3390\/molecules26247420","journal-title":"Molecules"},{"issue":"1","key":"6325_CR54","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1080\/14756366.2021.2004591","volume":"37","author":"LO Ortlieb","year":"2022","unstructured":"Ortlieb LO, Caruso \u00cdP, Mebus-Antunes NC, Poian D, Petronilho AT, Figueroa-Villar EdaC, Nascimento JD, C. J., Almeida FCL (2022) Searching for drug leads targeted to the hydrophobic cleft of dengue virus capsid protein. J Enzyme Inhib Med Chem 37(1):287\u2013298. https:\/\/doi.org\/10.1080\/14756366.2021.2004591","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"7","key":"6325_CR55","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1086\/597275","volume":"199","author":"W Peng","year":"2009","unstructured":"Peng W, Peltier DC, Larsen MJ, Kirchhoff PD, Larsen SD, Neubig RR, Miller DJ (2009) Identification of Thieno[3,2-b]Pyrrole Derivatives as Novel Small Molecule Inhibitors of Neurotropic Alphaviruses. J Infect Dis 199(7):950\u2013957. https:\/\/doi.org\/10.1086\/597275","journal-title":"J Infect Dis"},{"issue":"15","key":"6325_CR56","doi-asserted-by":"publisher","first-page":"4026","DOI":"10.1016\/j.bmcl.2006.05.012","volume":"16","author":"JM Ontoria","year":"2006","unstructured":"Ontoria JM, Mart\u00ecn Hernando JI, Malancona S, Attenni B, Stansfield I, Conte I, Ercolani C, Habermann J, Ponzi S, Di Filippo M, Koch U, Rowley M, Narjes F (2006) Identification of thieno[3,2-b]pyrroles as allosteric inhibitors of hepatitis C virus NS5B polymerase. Bioorganic Medicinal Chem Letters 16(15):4026\u20134030. https:\/\/doi.org\/10.1016\/j.bmcl.2006.05.012","journal-title":"Bioorganic Medicinal Chem Letters"},{"issue":"10","key":"6325_CR57","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1002\/cmdc.200900184","volume":"4","author":"JI Martin Hernando","year":"2009","unstructured":"Martin Hernando JI, Ontoria JM, Malancona S, Attenni B, Fiore F, Bonelli F, Koch U, Di Marco S, Colarusso S, Ponzi S, Gennari N, Vignetti SE, Del Rosario Rico Ferreira M, Habermann J, Rowley M, Narjes F (2009) Optimization of thienopyrrole-based finger-loop inhibitors of the hepatitis C virus NS5B polymerase. ChemMedChem 4(10):1695\u20131713. https:\/\/doi.org\/10.1002\/cmdc.200900184","journal-title":"ChemMedChem"},{"key":"6325_CR58","doi-asserted-by":"publisher","unstructured":"Salajkova S, Benkova M, Marek J, Sleha R, Prchal L, Malinak D, Dolezal R, Sep\u010di\u0107 K, Gunde-Cimerman N, Kuca K, Soukup O (2020) Wide-Antimicrobial Spectrum of Picolinium Salts. Molecules 25(9) Article 9. https:\/\/doi.org\/10.3390\/molecules25092254","DOI":"10.3390\/molecules25092254"},{"issue":"6A","key":"6325_CR59","first-page":"3773","volume":"21","author":"JA Fernandez-Pol","year":"2001","unstructured":"Fernandez-Pol JA, Klos DJ, Hamilton PD (2001) Antiviral, cytotoxic and apoptotic activities of picolinic acid on human immunodeficiency virus-1 and human herpes simplex virus-2 infected cells. Anticancer Res 21(6A):3773\u20133776","journal-title":"Anticancer Res"},{"issue":"8","key":"6325_CR60","doi-asserted-by":"publisher","first-page":"101127","DOI":"10.1016\/j.xcrm.2023.101127","volume":"4","author":"R Narayan","year":"2023","unstructured":"Narayan R, Sharma M, Yadav R, Biji A, Khatun O, Kaur S, Kanojia A, Joy CM, Rajmani R, Sharma PR, Jeyasankar S, Rani P, Shandil RK, Narayanan S, Rao DC, Satchidanandam V, Das S, Agarwal R, Tripathi S (2023) Picolinic acid is a broad-spectrum inhibitor of enveloped virus entry that restricts SARS-CoV-2 and influenza A virus in vivo. Cell Rep Med 4(8):101127. https:\/\/doi.org\/10.1016\/j.xcrm.2023.101127","journal-title":"Cell Rep Med"},{"key":"6325_CR61","unstructured":"Fernandez-Pol JA, Fernandez-Pol S (2010) Method to control dengue viruses in humans by picolinic acid and derivatives thereof. (United States Patent US 20100015174A1). https:\/\/patents.google.com\/patent\/US20100015174A1\/en"},{"issue":"5","key":"6325_CR62","first-page":"440","volume":"126","author":"R Shrivastava","year":"2007","unstructured":"Shrivastava R, Nagar R, Ravishankar GA, Upreti RK, Chaturvedi UC (2007) Effect of pretreatment with chromium picolinate on haematological parameters during dengue virus infection in mice. Indian J Med Res 126(5):440\u2013446","journal-title":"Indian J Med Res"},{"key":"6325_CR63","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.virol.2016.08.029","volume":"498","author":"R Sharma","year":"2016","unstructured":"Sharma R, Fatma B, Saha A, Bajpai S, Sistla S, Dash PK, Parida M, Kumar P, Tomar S (2016) Inhibition of chikungunya virus by picolinate that targets viral capsid protein. Virology 498:265\u2013276. https:\/\/doi.org\/10.1016\/j.virol.2016.08.029","journal-title":"Virology"},{"issue":"12","key":"6325_CR64","doi-asserted-by":"publisher","first-page":"e51288","DOI":"10.1371\/journal.pone.0051288","volume":"7","author":"M Aggarwal","year":"2012","unstructured":"Aggarwal M, Tapas S, Preeti, Siwach A, Kumar P, Kuhn RJ, Tomar S (2012) Crystal Structure of Aura Virus Capsid Protease and Its Complex with Dioxane: New Insights into Capsid-Glycoprotein Molecular Contacts. PLoS ONE 7(12):e51288. https:\/\/doi.org\/10.1371\/journal.pone.0051288","journal-title":"PLoS ONE"},{"issue":"6","key":"6325_CR65","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/j.jaci.2006.08.016","volume":"118","author":"MP Williamson","year":"2006","unstructured":"Williamson MP, McCormick TG, Nance CL, Shearer WT (2006) Epigallocatechin gallate, the main polyphenol in green tea, binds to the T-cell receptor, CD4: Potential for HIV-1 therapy. J Allergy Clin Immunol 118(6):1369\u20131374. https:\/\/doi.org\/10.1016\/j.jaci.2006.08.016","journal-title":"J Allergy Clin Immunol"},{"key":"6325_CR66","doi-asserted-by":"publisher","first-page":"133451","DOI":"10.1016\/j.ijbiomac.2024.133451","volume":"274","author":"Y He","year":"2024","unstructured":"He Y, Hao M, Yang M, Guo H, Rayman MP, Zhang X, Zhang J (2024) Influence of EGCG oxidation on inhibitory activity against the SARS-CoV-2 main protease. Int J Biol Macromol 274:133451. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.133451","journal-title":"Int J Biol Macromol"},{"issue":"21","key":"6325_CR67","doi-asserted-by":"publisher","first-page":"9743","DOI":"10.1128\/jvi.01382-16","volume":"90","author":"FS Varghese","year":"2016","unstructured":"Varghese FS, Thaa B, Amrun SN, Simarmata D, Rausalu K, Nyman TA, Merits A, McInerney GM, Ng LFP, Ahola T (2016) The Antiviral Alkaloid Berberine Reduces Chikungunya Virus-Induced Mitogen-Activated Protein Kinase Signaling. J Virol 90(21):9743\u20139757. https:\/\/doi.org\/10.1128\/jvi.01382-16","journal-title":"J Virol"},{"key":"6325_CR68","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.antiviral.2015.12.012","volume":"126","author":"FS Varghese","year":"2016","unstructured":"Varghese FS, Kaukinen P, Gl\u00e4sker S, Bespalov M, Hanski L, Wennerberg K, K\u00fcmmerer BM, Ahola T (2016) Discovery of berberine, abamectin and ivermectin as antivirals against chikungunya and other alphaviruses. Antiviral Res 126:117\u2013124. https:\/\/doi.org\/10.1016\/j.antiviral.2015.12.012","journal-title":"Antiviral Res"},{"issue":"6","key":"6325_CR69","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3390\/v9060151","volume":"9","author":"E Abdurakhmanov","year":"2017","unstructured":"Abdurakhmanov E, \u00d8ie Solbak S, Danielson UH (2017) Biophysical Mode-of-Action and Selectivity Analysis of Allosteric Inhibitors of Hepatitis C Virus (HCV) Polymerase. Viruses 9(6):151. https:\/\/doi.org\/10.3390\/v9060151","journal-title":"Viruses"},{"key":"6325_CR70","doi-asserted-by":"publisher","first-page":"104490","DOI":"10.1016\/j.bioorg.2020.104490","volume":"106","author":"K Mohamed","year":"2021","unstructured":"Mohamed K, Yazdanpanah N, Saghazadeh A, Rezaei N (2021) Computational drug discovery and repurposing for the treatment of COVID-19: A systematic review. Bioorg Chem 106:104490. https:\/\/doi.org\/10.1016\/j.bioorg.2020.104490","journal-title":"Bioorg Chem"},{"issue":"5","key":"6325_CR71","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.tibs.2017.02.006","volume":"42","author":"K Luck","year":"2017","unstructured":"Luck K, Sheynkman GM, Zhang I, Vidal M (2017) Proteome-Scale Human Interactomics. Trends Biochem Sci 42(5):342\u2013354. https:\/\/doi.org\/10.1016\/j.tibs.2017.02.006","journal-title":"Trends Biochem Sci"},{"key":"6325_CR72","doi-asserted-by":"publisher","first-page":"1292280","DOI":"10.3389\/fgene.2024.1292280","volume":"15","author":"A Tasneem","year":"2024","unstructured":"Tasneem A, Sultan A, Singh P, Bairagya HR, Almasoudi HH, Alhazmi AYM, Binshaya AS, Hakami MA, Alotaibi BS, Eisa A, Alolaiqy A, Hasan ASI, Dev MR, K., Dohare R (2024) Identification of potential therapeutic targets for COVID-19 through a structural-based similarity approach between SARS-CoV-2 and its human host proteins. Front Genet 15:1292280. https:\/\/doi.org\/10.3389\/fgene.2024.1292280","journal-title":"Front Genet"},{"key":"6325_CR73","doi-asserted-by":"publisher","first-page":"1325588","DOI":"10.3389\/fmolb.2023.1325588","volume":"10","author":"JX Lima Neto","year":"2023","unstructured":"Lima Neto JX, Bezerra KS, Barbosa ED, Araujo RL, Galv\u00e3o DS, Lyra ML, Oliveira JIN, Akash S, Jardan YAB, Nafidi H-A, Bourhia M, Fulco UL (2023) Investigation of protein-protein interactions and hotspot region on the NSP7-NSP8 binding site in NSP12 of SARS-CoV-2. Front Mol Biosci 10:1325588. https:\/\/doi.org\/10.3389\/fmolb.2023.1325588","journal-title":"Front Mol Biosci"},{"key":"6325_CR74","doi-asserted-by":"publisher","first-page":"114150","DOI":"10.1016\/j.ejmech.2022.114150","volume":"231","author":"X Fang","year":"2022","unstructured":"Fang X, Meng Q, Zhang H, Fang X, Huang LS, Zhang X, Schooley RT, Ciechanover A, An J, Xu Y, Huang Z (2022) A fragment integrational approach to GPCR inhibition: Identification of a high affinity small molecule CXCR4 antagonist. Eur J Med Chem 231:114150. https:\/\/doi.org\/10.1016\/j.ejmech.2022.114150","journal-title":"Eur J Med Chem"},{"issue":"2","key":"6325_CR75","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1002\/pro.4004","volume":"30","author":"Q Sun","year":"2021","unstructured":"Sun Q, Ramaswamy VSK, Levy R, Deng N (2021) Computational design of small molecular modulators of protein\u2013protein interactions with a novel thermodynamic cycle: Allosteric inhibitors of HIV-1 integrase. Protein Science: Publication Protein Soc 30(2):438\u2013447. https:\/\/doi.org\/10.1002\/pro.4004","journal-title":"Protein Science: Publication Protein Soc"},{"issue":"6","key":"6325_CR76","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1099\/vir.0.008565-0","volume":"90","author":"S Kota","year":"2009","unstructured":"Kota S, Coito C, Mousseau G, Lavergne J-P, Strosberg AD (2009) Peptide inhibitors of hepatitis C virus core oligomerization and virus production. J Gen Virol 90(6):1319\u20131328. https:\/\/doi.org\/10.1099\/vir.0.008565-0","journal-title":"J Gen Virol"},{"key":"6325_CR77","doi-asserted-by":"publisher","first-page":"105011","DOI":"10.1016\/j.antiviral.2021.105011","volume":"186","author":"F Lasala","year":"2021","unstructured":"Lasala F, Garc\u00eda-Rubia A, Requena C, Galindo I, Cuesta-Geijo MA, Garc\u00eda-Dorival I, Bueno P, Labiod N, Luczkowiak J, Martinez A, Campillo NE, Alonso C, Delgado R, Gil C (2021) Identification of potential inhibitors of protein-protein interaction useful to fight against Ebola and other highly pathogenic viruses. Antiviral Res 186:105011. https:\/\/doi.org\/10.1016\/j.antiviral.2021.105011","journal-title":"Antiviral Res"},{"issue":"24","key":"6325_CR78","doi-asserted-by":"publisher","first-page":"5155","DOI":"10.1039\/C7OB00012J","volume":"15","author":"X Song","year":"2017","unstructured":"Song X, Lu L, Passioura T, Suga H (2017) Macrocyclic peptide inhibitors for the protein\u2013protein interaction of Zaire Ebola virus protein 24 and karyopherin alpha 5. Organic Biomolecular Chemistry 15(24):5155\u20135160. https:\/\/doi.org\/10.1039\/C7OB00012J","journal-title":"Organic Biomolecular Chemistry"},{"key":"6325_CR79","doi-asserted-by":"publisher","unstructured":"Santos IA, Shimizu JF, de Oliveira DM, Martins DOS, Cardoso-Sousa L, Cintra ACO, Aquino VH, Sampaio SV, Nicolau-Junior N, Sabino-Silva R, Merits A, Harris M, Jardim ACG (2021) Chikungunya virus entry is strongly inhibited by phospholipase A2 isolated from the venom of Crotalus durissus terrificus. Sci Rep 11(1). Article 1. https:\/\/doi.org\/10.1038\/s41598-021-88039-4","DOI":"10.1038\/s41598-021-88039-4"},{"key":"6325_CR80","doi-asserted-by":"publisher","unstructured":"Ayusso GM, da Silva Sanches PR, Carvalho T, Santos IA, Martins DOS, Lima MLD, da Concei\u00e7\u00e3o PJP, Bittar C, Merits A, Cilli EM, Jardim ACG, Rahal P, Calmon MF (2023) The Synthetic Peptide GA-Hecate and Its Analogs Inhibit Multiple Steps of the Chikungunya Virus Infection Cycle In Vitro. Pharmaceuticals. 16(10). Article 10. https:\/\/doi.org\/10.3390\/ph16101389","DOI":"10.3390\/ph16101389"},{"issue":"7","key":"6325_CR81","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1016\/j.cell.2019.04.008","volume":"177","author":"H Song","year":"2019","unstructured":"Song H, Zhao Z, Chai Y, Jin X, Li C, Yuan F, Liu S, Gao Z, Wang H, Song J, Vazquez L, Zhang Y, Tan S, Morel CM, Yan J, Shi Y, Qi J, Gao F, Gao GF (2019) Molecular Basis of Arthritogenic Alphavirus Receptor MXRA8 Binding to Chikungunya Virus Envelope Protein. Cell 177(7):1714\u20131724e12. https:\/\/doi.org\/10.1016\/j.cell.2019.04.008","journal-title":"Cell"},{"issue":"11","key":"6325_CR82","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.3390\/v11111078","volume":"11","author":"BS Schnierle","year":"2019","unstructured":"Schnierle BS (2019) Cellular Attachment and Entry Factors for Chikungunya Virus. Viruses 11(11):1078. https:\/\/doi.org\/10.3390\/v11111078","journal-title":"Viruses"},{"issue":"1","key":"6325_CR83","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41572-023-00429-2","volume":"9","author":"K Bartholomeeusen","year":"2023","unstructured":"Bartholomeeusen K, Daniel M, LaBeaud DA, Gasque P, Peeling RW, Stephenson KE, Ng LFP, Ari\u00ebn KK (2023) Chikungunya fever. Nat Reviews Disease Primers 9(1):17. https:\/\/doi.org\/10.1038\/s41572-023-00429-2","journal-title":"Nat Reviews Disease Primers"},{"issue":"3","key":"6325_CR84","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/1348-0421.12230","volume":"59","author":"P Wintachai","year":"2015","unstructured":"Wintachai P, Thuaud F, Basmadjian C, Roytrakul S, Ubol S, D\u00e9saubry L, Smith DR (2015) Assessment of flavaglines as potential chikungunya virus entry inhibitors. Microbiol Immunol 59(3):129\u2013141. https:\/\/doi.org\/10.1111\/1348-0421.12230","journal-title":"Microbiol Immunol"},{"issue":"1","key":"6325_CR85","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.jviromet.2008.07.031","volume":"154","author":"B Cho","year":"2008","unstructured":"Cho B, Kim J, Cho J-E, Jeon B-Y, Park S (2008) Expression of the capsid protein of Chikungunya virus in a baculovirus for serodiagnosis of Chikungunya disease. J Virol Methods 154(1):154\u2013159. https:\/\/doi.org\/10.1016\/j.jviromet.2008.07.031","journal-title":"J Virol Methods"},{"issue":"1","key":"6325_CR86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep14753","volume":"5","author":"M Aggarwal","year":"2015","unstructured":"Aggarwal M, Sharma R, Kumar P, Parida M, Tomar S (2015) Kinetic characterization of trans- proteolytic activity of Chikungunya virus capsid protease and development of a FRET-based HTS assay. Sci Rep 5(1):1\u201312. https:\/\/doi.org\/10.1038\/srep14753","journal-title":"Sci Rep"},{"key":"6325_CR87","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.ejmech.2014.10.010","volume":"87","author":"S Bhakat","year":"2014","unstructured":"Bhakat S, Karubiu W, Jayaprakash V, Soliman MES (2014) A perspective on targeting non-structural proteins to combat neglected tropical diseases: Dengue, West Nile and Chikungunya viruses. Eur J Med Chem 87:677\u2013702. https:\/\/doi.org\/10.1016\/j.ejmech.2014.10.010","journal-title":"Eur J Med Chem"},{"issue":"1","key":"6325_CR88","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3390\/pharmaceutics15010049","volume":"15","author":"Y Chang","year":"2022","unstructured":"Chang Y, Hawkins BA, Du JJ, Groundwater PW, Hibbs DE, Lai F (2022) A Guide to. Silico Drug Des Pharmaceutics 15(1):49. https:\/\/doi.org\/10.3390\/pharmaceutics15010049","journal-title":"Silico Drug Des Pharmaceutics"},{"issue":"6","key":"6325_CR89","doi-asserted-by":"publisher","first-page":"e0042024","DOI":"10.1128\/mbio.00420-24","volume":"15","author":"P Yin","year":"2024","unstructured":"Yin P, May NA, Lello LS, Fayed A, Parks MG, Drobish AM, Wang S, Andrews M, Sticher Z, Kolykhalov AA, Natchus MG, Painter GR, Merits A, Kielian M, Morrison TE (2024) 4\u2019-Fluorouridine inhibits alphavirus replication and infection in vitro and in vivo. mBio 15(6):e0042024. https:\/\/doi.org\/10.1128\/mbio.00420-24","journal-title":"mBio"},{"issue":"7","key":"6325_CR90","doi-asserted-by":"publisher","first-page":"e0046322","DOI":"10.1128\/aac.00463-22","volume":"66","author":"S De","year":"2022","unstructured":"De S, Ghosh S, Keshry SS, Mahish C, Mohapatra C, Guru A, Mamidi P, Datey A, Pani SS, Vasudevan D, Beuria TK, Chattopadhyay S, Subudhi BB, Chattopadhyay S (2022) MBZM-N-IBT, a Novel Small Molecule, Restricts Chikungunya Virus Infection by Targeting nsP2 Protease Activity In Vitro, In Vivo, and Ex Vivo. Antimicrob Agents Chemother 66(7):e0046322. https:\/\/doi.org\/10.1128\/aac.00463-22","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"6325_CR91","doi-asserted-by":"publisher","first-page":"2270074","DOI":"10.1080\/22221751.2023.2270074","volume":"12","author":"V Cao","year":"2023","unstructured":"Cao V, Loeanurit N, Hengphasatporn K, Hairani R, Wacharachaisurapol N, Prompila N, Wittayalertpanya S, Shigeta Y, Khotavivattana T, Chavasiri W, Boonyasuppayakorn S (2023) The 8-bromobaicalein alleviated chikungunya-induced musculoskeletal inflammation and reduced the viral load in healthy adult mice. Emerging Microbes Infections 12(2):2270074. https:\/\/doi.org\/10.1080\/22221751.2023.2270074","journal-title":"Emerging Microbes Infections"},{"issue":"4","key":"6325_CR92","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/COH.0000000000000472","volume":"13","author":"SK Carnes","year":"2018","unstructured":"Carnes SK, Sheehan JH, Aiken C (2018) Inhibitors of the HIV-1 capsid, a target of opportunity. Curr Opin HIV AIDS 13(4):359. https:\/\/doi.org\/10.1097\/COH.0000000000000472","journal-title":"Curr Opin HIV AIDS"},{"issue":"4","key":"6325_CR93","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1128\/AAC.02574-15","volume":"60","author":"S Thenin-Houssier","year":"2016","unstructured":"Thenin-Houssier S, de Vera IMS, Pedro-Rosa L, Brady A, Richard A, Konnick B, Opp S, Buffone C, Fuhrmann J, Kota S, Billack B, Pietka-Ottlik M, Tellinghuisen T, Choe H, Spicer T, Scampavia L, Diaz-Griffero F, Kojetin DJ, Valente ST (2016) Ebselen, a Small-Molecule Capsid Inhibitor of HIV-1 Replication. Antimicrob Agents Chemother 60(4):2195\u20132208. https:\/\/doi.org\/10.1128\/AAC.02574-15","journal-title":"Antimicrob Agents Chemother"},{"key":"6325_CR94","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ijsu.2020.10.018","volume":"84","author":"CV Haritha","year":"2020","unstructured":"Haritha CV, Sharun K, Jose B (2020) Ebselen, a new candidate therapeutic against SARS-CoV-2. Int J Surg (London England) 84:53\u201356. https:\/\/doi.org\/10.1016\/j.ijsu.2020.10.018","journal-title":"Int J Surg (London England)"},{"key":"6325_CR95","doi-asserted-by":"publisher","unstructured":"Pachota M, Grzywa R, Iwanejko J, Synowiec A, Iwan D, Kami\u0144ska K, Skore\u0144ski M, Bielecka E, Szczubia\u0142ka K, Nowakowska M, Mackereth CD, Wojaczy\u0144ska E, Sie\u0144czyk M, Pyr\u0107 K (2023) Novel inhibitors of HSV-1 protease effective in vitro and in vivo. Antiviral Res 213:105604. https:\/\/doi.org\/10.1016\/j.antiviral.2023.105604","DOI":"10.1016\/j.antiviral.2023.105604"}],"container-title":["Archives of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-025-06325-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00705-025-06325-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-025-06325-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T10:02:02Z","timestamp":1779357722000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00705-025-06325-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,27]]},"references-count":95,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["6325"],"URL":"https:\/\/doi.org\/10.1007\/s00705-025-06325-2","relation":{},"ISSN":["0304-8608","1432-8798"],"issn-type":[{"value":"0304-8608","type":"print"},{"value":"1432-8798","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,27]]},"assertion":[{"value":"3 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"141"}}